These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23227500)

  • 1. [Alginates in the treatment of postgastroresection reflux esophagitis].
    Ianova OB; Kim VA; Treĭman EV
    Ter Arkh; 2012; 84(10):48-50. PubMed ID: 23227500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].
    Mandel KG; Deggi BP; Brodi DA; Jeykobi GI
    Eksp Klin Gastroenterol; 2008; (4):64-77. PubMed ID: 19145905
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estimation of efficiency of alginate-raft barrier in treatment of gastroesophageal reflux disease].
    Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
    Eksp Klin Gastroenterol; 2008; (6):77-81. PubMed ID: 19334430
    [No Abstract]   [Full Text] [Related]  

  • 4. [Alginate improves symptom control].
    Siegmund-Schultze N
    MMW Fortschr Med; 2016 Jun; 158(11):76. PubMed ID: 27271425
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
    Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
    Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
    [No Abstract]   [Full Text] [Related]  

  • 6. [The experience of usage of alginate contain medication in complex therapy at children with GERD disease].
    Shcherbakov PL; Lobanov IuF; Fugol DS; Shilova AV
    Eksp Klin Gastroenterol; 2009; (5):81-4. PubMed ID: 20201310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multicenter study of sodium alginate in the treatment of regurgitation in infants].
    Le Luyer B; Mougenot JF; Mashako L; Chapoy P; Olives JP; Morali A; Chevallier B; Ginies JL; Dupont C; Dagorne M
    Ann Pediatr (Paris); 1992 Dec; 39(10):635-40. PubMed ID: 1485782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastroesophageal reflux disease during pregnancy].
    Elokhina TB; Tiutiunnik VL
    Eksp Klin Gastroenterol; 2009; (3):93-7. PubMed ID: 19928006
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of food and acid reflux in patients with low-grade oesophagitis--the role of an anti-reflux agent.
    Washington N; Steele RJ; Jackson SJ; Washington C; Bush D
    Aliment Pharmacol Ther; 1998 Jan; 12(1):53-8. PubMed ID: 9692701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of action, efficacy, and onset dynamics of a single dose of alginates in patients with heartburn and GERD].
    Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
    Eksp Klin Gastroenterol; 2009; (4):77-85. PubMed ID: 19960998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of alginate test in gastroesophageal reflux disease].
    Bordin DS; Masharova AA; Droxzdov VN; Firsova LD; Kozhurina TS
    Eksp Klin Gastroenterol; 2010; (12):102-7. PubMed ID: 21560632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms.
    Yuan YZ; Fang JY; Zou DW; Levinson N; Jenner B; Wilkinson J
    J Dig Dis; 2016 Nov; 17(11):725-734. PubMed ID: 27622897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Using gaviscon preparation for relief of esophageal, extraesophageal syndromes and functional dyspepsia in elderly patients with GERD].
    Onuchina EV; Brikova SI; Tsukanov VV
    Eksp Klin Gastroenterol; 2010; (10):80-6. PubMed ID: 21434379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Restoration of the quality of life by eliminating and prevention of heartburn by alginate: results of multicenter study "VIA APIA"].
    Lazebnik LB; Bordin DS; Masharova AA; Dzhulaĭ GS; Butov MA; Abdulkhakov RA; Eremina EIu; Tarasova LV; Safonova OV; Firsova LD; Kozhurina TS
    Eksp Klin Gastroenterol; 2010; (6):70-6. PubMed ID: 20731169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis: results of prospective double-blind randomised clinical trial.
    Eriksen CA; Cheadle WG; Cranford CA; Cuschieri A
    Ann Chir Gynaecol; 1988; 77(4):133-7. PubMed ID: 2855391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
    Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Failure of amiodarone in supraventricular tachycardia in an infant: drug interaction with Gaviscon(®)?].
    Chantepie A; Lefort B; Méot M; Jandali JC; Soulé N; Chantreuil J; Vaillant MC; Tisseron B
    Arch Pediatr; 2014 Jun; 21(6):663-4. PubMed ID: 24768351
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic procedures in gastroesophageal reflux disease].
    Tytgat GN
    Z Gastroenterol; 1986 Sep; 24 Suppl 2():40-4. PubMed ID: 2877526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
    Wilkinson J; Wade A; Thomas SJ; Jenner B; Hodgkinson V; Coyle C
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):86-93. PubMed ID: 30272584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.
    Coyle C; Crawford G; Wilkinson J; Thomas SJ; Bytzer P
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1524-1533. PubMed ID: 28464343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.